| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef5e904cf1809a25fd9635d621506632 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2410-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96466
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-86 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 |
| filingDate |
2002-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57d51431f02e90e4f8cd2a2178be7473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f18a03406da5c1e0db588bec97a7b6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6d1b4548e9eecad6c76c6661befb793 |
| publicationDate |
2003-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2003036208-A1 |
| titleOfInvention |
Drug screening and diagnosis based on paracrine tubular renin-angiotensin system |
| abstract |
The present invention relates to a method for screening drugs for use in treating hypertension using the tubular renin-angiotensinogen system identified by the present invention. The invention further relates to a method to diagnose sodium status and sensitivity in an individual by measuring urinary angiotensinogen or angiotensin-I. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8855397-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006292615-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010148411-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013084598-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011044963-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008026409-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010104646-A1 |
| priorityDate |
1998-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |